Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
World Journal of Nuclear Medicine|May 3, 2018
Ra223 in Bone Metastases with Osteolytic ActivityRenato Patrizio Costa, Davide Cardile, Alessandra Murabito, et al.
Oncology|December 15, 2017
The Clinical Efficacy of Radium-223 for Bone Metastasis in Patients with Castration-Resistant Prostate Cancer: An Italian Clinical ExperienceRossella De Luca, Renato Patrizio Costa, Vincenzo Tripoli, et al.
Acta Oto-Laryngologica|May 23, 2009
Botulinum toxin in preparation of oral cavity for microsurgical reconstructionBartolo Corradino, Sara Di Lorenzo, Carmela Mossuto, et al.
World Journal of Nuclear Medicine|September 14, 2019
Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?Renato Patrizio Costa, Vincenzo Tripoli, Alessandro Princiotta, et al.
Annali Italiani Di Chirurgia|May 27, 2015
The intraoperative use of the mini-gamma camera (MGC) in the surgical treatment of primary hyperparathyroidism: Technical reports and immediate results from the initial experienceGregorio Scerrino, Serena Castorina, Giuseppina Irene Melfa, et al.
Future Oncology (London, England)|January 29, 2021
Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patientsOrazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 26, 2021
Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without <sup>223</sup>RaOrazio Caffo, Viviana Frantellizzi, Fabio Monari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2021
The prognostic power of inflammatory indices and clinical factors in metastatic castration-resistant prostate cancer patients treated with radium-223 (BIO-Ra study)Matteo Bauckneht, Sara Elena Rebuzzi, Alessio Signori, et al.
Diagnostics (Basel, Switzerland)|February 13, 2025
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with <sup>223</sup>RaCl<sub>2</sub>: Ten Years of Clinical ExperienceMaria Silvia De Feo, Luca Filippi, Matteo Bauckneht, et al.
Cancers|April 12, 2022
Prognostic Value of the BIO-Ra Score in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Radium-223 after the European Medicines Agency Restricted Use: Secondary Investigations of the Multicentric BIO-Ra StudyMatteo Bauckneht, Sara Elena Rebuzzi, Marta Ponzano, et al.
Pageof 1